1. Home
  2. Analysis
  3. Lorazepam
  4. Temsirolimus

Lorazepam and Temsirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 92 people who take Lorazepam and Temsirolimus. Common interactions include nephrotic syndrome among females, and disease progression among males.

The phase IV clinical study analyzes what interactions people who take Lorazepam and Temsirolimus have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2023

92 people who take Lorazepam and Temsirolimus together, and have interactions are studied.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is used in stress and anxiety. Currently, eHealthMe is studying from 157,093 Lorazepam users.

What is Temsirolimus?

Temsirolimus has active ingredients of temsirolimus. Currently, eHealthMe is studying from 3,527 Temsirolimus users.

Number of Lorazepam and Temsirolimus reports submitted per year:

Lorazepam and Temsirolimus drug interactions.

Common Lorazepam and Temsirolimus drug interactions by gender *:

female:

  1. Nephrotic syndrome
  2. Platelet count decreased
  3. Febrile bone marrow aplasia
  4. Mucosal inflammation
  5. Haemoglobin increased
  6. Polycythaemia
  7. Nausea
  8. Urinary tract infection
  9. Urosepsis
  10. Deep vein thrombosis

male:

  1. Disease progression
  2. Sepsis
  3. Abdominal pain upper
  4. Bacteraemia
  5. Brain herniation
  6. Fall
  7. Gait disturbance
  8. Grand mal convulsion
  9. Hypokalaemia
  10. Mental disorder

Common Lorazepam and Temsirolimus drug interactions by age *:

0-1:

n/a

2-9:

  1. Febrile neutropenia
  2. Stomatitis

10-19:

  1. Enterocolitis
  2. Neutropenia
  3. Stomatitis
  4. Hyperglycaemia
  5. Platelet count decreased
  6. Headache
  7. Anaemia
  8. Ascites
  9. Epistaxis
  10. Febrile neutropenia

20-29:

n/a

30-39:

  1. Respiratory failure
  2. Septic shock
  3. Immunodeficiency
  4. Pneumonia
  5. Asthenia
  6. Facial pain
  7. Failure to thrive
  8. Mental status changes
  9. Sepsis
  10. Diarrhoea

40-49:

  1. Dehydration
  2. Abdominal pain
  3. Constipation
  4. Hepatic haemorrhage
  5. Hepatic rupture
  6. Peritoneal haemorrhage
  7. Ventricular tachycardia
  8. Cardiac arrest
  9. Cardiomyopathy
  10. Disease progression

50-59:

  1. Nausea
  2. Renal cell carcinoma
  3. Somnolence
  4. Actinic keratosis
  5. Adrenal insufficiency
  6. Anaemia of malignant disease
  7. Arteriosclerosis
  8. Arthralgia
  9. Asthenia
  10. Back pain

60+:

  1. Sepsis
  2. Colitis
  3. Gastric perforation
  4. Blood creatinine increased
  5. Cardio-respiratory arrest
  6. Hypoxia
  7. Meningitis
  8. Meningitis bacterial
  9. Pleural effusion
  10. Pyrexia

Common conditions people have *:

  1. High Blood Pressure: 27 people, 29.35%
  2. Insomnia (sleeplessness): 25 people, 27.17%
  3. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 22 people, 23.91%
  4. High Blood Cholesterol: 19 people, 20.65%
  5. Diarrhea: 19 people, 20.65%
  6. Nausea And Vomiting: 18 people, 19.57%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 15.22%
  8. Cough: 13 people, 14.13%
  9. Constipation: 12 people, 13.04%
  10. Diabetes: 12 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Temsirolimus?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Lorazepam drug interactions:

Browse interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Temsirolimus drug interactions:

Browse interactions between Temsirolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and temsirolimus (the active ingredients of Lorazepam and Temsirolimus, respectively), and Lorazepam and Temsirolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lorazepam and Temsirolimus.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.